Morgan Lewis

Life Sciences Related News

For More Information

Read the Brochure

Life Sciences and Healthcare

Life Sciences Deskbook

New Resource

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Industry Events


Practice Highlights

Honors

PLCCross-border Quarterly 2011/12 Life Sciences Legal Market Review

  • Life Sciences Regulatory Super League - Ranked 10th of law firms worldwide

PLCCross-border Life Sciences Handbook 2011/12

  • U.S.:
    • Commercial and Partnering - Highly Recommended
    • Competition/Antitrust - Highly Recommended
    • Corporate - Recommended
    • Government Enforcement and Investigations - Highly Recommended
    • Regulatory - Recommended
    • Regulatory (Medical Devices) - Recommended
  • England: Regulatory - Recommended
  • Japan: Corporate and Commercial - Recommended

Chambers Global 2011: Global Life Sciences - Recommended - Band 3

Chambers USA 2011: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3

UK Legal 500 2010: London: Pharmaceuticals and Biotechnology

Best Lawyers in America 2011: Biotechnology and Healthcare Law Named

BioPharm Insight 2011

  • Ranked 3rd - Global League Table of Legal Advisers on Licensing Agreements - Based upon Volume
  • Ranked 6th - Global League Table of Legal Advisers on Licensing Agreements - Based upon Value
  • Ranked 4th - League Table of Legal Advisers on North American Licensing Agreements - Based upon Volume
  • Ranked 9th - League Table of Legal Advisers on North American Licensing Agreements - Based upon Value
  • Ranked 3rd - League Table of Legal Advisers on European Licensing Agreements - Based upon Volume
  • Ranked 4th - League Table of Legal Advisers on European Licensing Agreements - Based upon Value
  • Ranked 2nd - League Table of Legal Advisers on Asia-Pacific Licensing Agreements - Based upon Volume
  • Ranked 5th - League Table of Legal Advisers on Asia-Pacific Licensing Agreements - Based upon Value
U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

9 of the top 20 medical device companies

Related Events

02/27/12-02/29/12 ACI’s 16th Advanced Forum on Structuring, Negotiating, and Managing Life Sciences Collaborative Agreements and Acquisitions New York
Fahd Riaz, panelist, "Preparing Your IP for M&A or Product License: What Savvy Buyers Look For"
02/29/12-03/02/12 2012 IMS Managed Markets Services/DataNiche Conference Las Vegas, NV
Donna Lee Yesner, speaker
03/29/12-03/31/12 National Hospice and Palliative Care Organization (NHPCO) 27th Management and Leadership Conference National Harbor, MD
Howard Young, panelist, "The OIG and Hospice in Nursing Facilities: Past, Present and Future"
View all events

Related News

01/04/12 Former VP and Deputy GC of Cephalon Joins Morgan Lewis
Morgan Lewis today announces that Steven A. Reed has joined the firm as a partner in its Litigation Practice, resident in Philadelphia.
01/20/11 Morgan Lewis Advises Perrigo on $540 Million Acquisition of Paddock Assets
Morgan Lewis advised Perrigo Company, a global healthcare products supplier, on its acquisition of nearly all of the assets of Paddock Laboratories, Inc. for $540 million in cash.
10/29/10 Morgan Lewis Advises Safeguard Scientifics on $587 Million Sale of Clarient to GE Healthcare
In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.
View all news

Related Publications

02/09/12 FDA Issues Three Draft Guidances for Biosimilars
Initial guidance provides insights on regulatory pathway for biosimilars, but does not address many critical issues.
02/06/12 CMS Proposes Major Changes to AMP Rule
The Proposed Rule provides provisions that will significantly impact pharmaceutical manufacturers' rebate liability, price reporting calculations, and possibly their operations.
02/03/12 Class Action Arbitration Waiver Rejected by Federal Appellate Court
Second Circuit sidesteps Concepcion and holds that the ability to enforce federal statutory rights mandates that a plaintiff be allowed to pursue a class action in court notwithstanding the parties' agreement to mandatory arbitration.
View all publications
32 news articles found
page 2 of 2
Dec 13, 2005 - Morgan Lewis’ Life Sciences Practice Recommended in PLC Cross-border Life Sciences Handbook

Morgan Lewis is pleased to announce that Practical Law Company recommends the firm’s Life Sciences Practice and its attorneys in the PLCCross-border Life Sciences Handbook 2005/06.

Sep 28, 2005 - Morgan Lewis Announces New Joint Venture with TMI Associates, The Sixth Largest Law Firm in Japan

Morgan Lewis & Bockius LLP, a global law firm, today announced a new joint venture with TMI Associates, one of the top law firms in Japan, effective immediately. The new partnership, named Morgan Lewis-TMI, will focus primarily on cross-border corpora

Feb 09, 2004 - Morgan Lewis Expands Life Science Practice Capabilities
Oct 06, 2003 - Former Pharmacia General Counsel Richard T. Collier Joins Morgan Lewis
Dec 02, 2002 - Morgan Lewis Represents Enzon in $360 Million Purchase of Abelcet® North American Business From Elan
Apr 09, 2002 - Morgan Lewis London Partner Named Leading Life Sciences Lawyer
Jun 11, 2001 - Morgan Lewis Opens Northern Virginia Office and Extends Reach of Global Technology Practice
page 2 of 2